a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer

The primary endpoint of the present prospective study is to assess the outcomes in terms of acute toxicity of post-operative stereotactic radiotherapy for endometrial cancer

Trial Details

NCT ID
NCT06360653
Phase
NA
Sponsor
ARNAS Civico Di Cristina Benfratelli Hospital
Status
RECRUITING
Cancer Type
Endometrial Cancer Uterine Cancer
Interventions
  • Stereotactic Post-operative Radiotherapy for Endometrial Cancer
Locations (sample)
  • Palermo, Italy|38.1166,13.3636
  • Palermo, Italy|38.1166,13.3636

Key Eligibility Criteria

  • Age 18-80 years
  • ECOG PS ≤ 2 or KPS ≥ 70%
  • Patients diagnosed with endometrial cancer (endometrioid, serous cell, clear cell, carcinosarcoma) FIGO stage IB-IIIC1 candidate to post-operative …
  • Indications for chemotherapy and/or brachytherapy are not exclusion criteria for the purpose of the study

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Endometrial Cancer Uterine Cancer Trials on Trialify →